Acadia Healthcare vs Concentra Group Holdings Parent
ACHC and CON side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ACHC and CON compare
Concentra Group Holdings Parent is the larger company, worth 1.5 times as much as Acadia Healthcare ($5.5B against $3.6B).
Concentra Group Holdings Parent grew revenue faster over the last twelve months (11.8% versus 4.5% for Acadia Healthcare).
Concentra Group Holdings Parent keeps more of each dollar of sales as profit, with a net margin of 9.3% compared with −33.1% at Acadia Healthcare.
Concentra Group Holdings Parent pays a dividend yielding 0.58%; Acadia Healthcare does not pay one.
Concentra Group Holdings Parent scores higher on the StockData Score (12 against 7 for Acadia Healthcare), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ACHC | CON |
|---|---|---|
| Size and price | ||
| Market cap | $3.6B | $5.5B |
| Share price | $38.80 | $43.45 |
| Change, 1 year | 114% | 126% |
| Change, 5 years | −37.3% | – |
| Beta (5Y) | 0.60 | 0.50 |
| Employees | 25K | 13K |
| StockData Score | ||
| Total score | 7 | 12 (better) |
| Valuation score | 3 (better) | 0 |
| Growth score | 2 | 3 (better) |
| Performance score | 0 | 4 (better) |
| Health score | 2 | 2 |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/E | – | 25.9× |
| P/S | 1.1× (better) | 2.4× |
| P/B | 1.8× (better) | 10.9× |
| EV/EBITDA | – | 14.7× |
| P/FCF | – | 21.5× |
| FCF yield | −0.66% | 4.6% (better) |
| Fair value | $71.81 | $36.45 |
| Margin of safety | 46.0% (better) | −19.2% |
| Growth | ||
| Revenue growth (TTM) | 4.5% | 11.8% (better) |
| Revenue growth, 5Y average | 9.7% | – |
| Net income growth (TTM) | −1151% | 41.2% (better) |
| EPS growth (TTM) | −1183% | 40.0% (better) |
| Profitability | ||
| Gross margin | – | 29.9% |
| Operating margin | – | 16.9% |
| Net margin | −33.1% | 9.3% (better) |
| FCF margin | −0.70% | 11.0% (better) |
| Return on equity | −43.9% | 48.5% (better) |
| Return on invested capital | – | 15.6% |
| Financial health | ||
| Debt / equity | 1.16 (better) | 3.00 |
| Net debt / EBITDA | – | 3.02 |
| Current ratio | 1.60 (better) | 1.30 |
| Altman Z-score | 1.16 | 2.74 (better) |
| Piotroski F-score | 4 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 0.58% |
| Payout ratio | – | 14.8% |
| Years of dividend growth | – | 1 |
| Buyback yield | – | 1.5% |
| Shareholder yield | 0.00% | 2.1% (better) |
| Ownership | ||
| Held by institutions | 145% | 88.2% |
| Held by insiders | 1.9% | 11.3% |
| Insider net buying, 12 months | – | −$14.6M |
| Short interest, % of float | 20.8% | 2.0% |
Go deeper
- ACHC stock overview
- ACHC income statement
- ACHC valuation and score
- CON stock overview
- CON income statement
- CON valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.